Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
HALOCYCLOPROPANATION PROCESSES
Document Type and Number:
WIPO Patent Application WO/2022/235863
Kind Code:
A1
Abstract:
This disclosure relates to halocyclopropanation processes useful in forming molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda.

Inventors:
BARTON THOMAS J (US)
CABRERA VENTURA PABLO JOSE (US)
GOOD STEFFEN N (US)
LI FANGZHENG (US)
ROSENTHAL TAY (US)
SCHUITMAN ABRAHAM D (US)
VERMEULEN NICOLAAS A (US)
Application Number:
PCT/US2022/027768
Publication Date:
November 10, 2022
Filing Date:
May 05, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CORTEVA AGRISCIENCE LLC (US)
International Classes:
C07C41/48; C07C43/313; C07F7/02; C07F9/66
Domestic Patent References:
WO2016168059A12016-10-20
WO2021216629A12021-10-28
WO2016168056A12016-10-20
WO2016168058A12016-10-20
WO2016168059A12016-10-20
WO2018071320A12018-04-19
WO2018071327A12018-04-19
Attorney, Agent or Firm:
CORVIN, Carl D. (US)
Download PDF:
Claims:
WE CLAIM

1. A process comprising halocyclopropanating S1a to produce S1b in the presence of hexachloroacetone and lithium tert-butoxide wherein

(a) R1, R2, R3, R4, and R5 are each independently H, F, Cl, Br, I, CN, NH2, NO2, (C1-C4)alkyl, (C1-C4)alkoxy, (C1-C4)haloalkyl, or (C1-C4)haloalkoxy;

(b) each Rn is independently a (C1-C4)alkyl, or both Rn substituents together form a (C2- Ce)alkyl link between the two oxygen atoms; and

(c) each X is independently F, Cl, Br, or I.

2. A process comprising halocyclopropanating S2a to produce S2b-major product in the presence of hexachloroacetone and lithium tert-butoxide

S2b-major product wherein

(a) R1, R2, R3, R4, and R5 are each independently H, F, Cl, Br, I, CN, NH2, NO2, (C1-C4)alkyl, (C1-C4)alkoxy, (C1-C4)haloalkyl, or (C1-C4)haloalkoxy; (b) each Y is independently a OH, OSi((C1-C4)alkyl)3, OSi((C1-C4)alkyl)2((C1-C4)alkyl-aryl), OSi((C1-C4)alkyl) (aryl), OSi((C1-C4)alkyl)(aryl) , OC(O)(C1-C4)alkyl, OC(O)O(C1-C4)alkyl, OC(O)NH(C1- C4)alkyl, O(C1-C4)alkyi-aryl, O-aryl, tetrahydropyranyl, or 1,3-dioxolanyl; and

(c) each X is independently F, Cl, Br, or I.

3. A composition comprising the following molecule. (E)-1 -(3,3-diethoxyprop-1 -en-1 -yl)-3,5- bis(trifluoromethyl)benzene

4. A molecule having the following structure (5R, 6R)-5,6-bis((E)-3,5-bis(trifluoromethyl)styryl)-2,2,3,3,8,8,9,9-octamethyl-

4,7-dioxa-3,8-disiladecane

5. A molecule having the following structure (5R, 6R)-5,6-bis((1R, 3R)-3-(3,5-bis(trifluoromethyl)phenyl)-

2,2-dichlorocyclopropyl)-2,2,3,3,8,8,9,9-octamethyl-4,7- dioxa-3,8-disiladecane

Description:
HALOCYCLOPROPANATION PROCESSES

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of, and priority from, U.S. provisional application serial number 63/185,399, which was filed 07 MAY 2021. The entire content of this provisional application is hereby incorporated by reference.

FIELD OF THIS DISCLOSURE

This disclosure relates to halocyclopropanation processes useful in forming molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda.

BACKGROUND OF THIS DISCLOSURE

Halocyclopropanation processes have been disclosed in applications WO/2016/168056; WO/2016/168058; WO/2016/168059; WO/2018/071320; and WO/2018/071327.

DEFINITIONS USED IN THIS DISCLOSURE

The examples given in these definitions are not exhaustive. It is understood that a substituent should comply with chemical bonding rules and steric compatibility constraints in relation to the particular molecule to which it is attached. These definitions are only to be used for the purposes of this disclosure.

The term “alkoxy” means an alkyl further consisting of a carbon-oxygen single bond, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, isobutoxy, and tert-butoxy.

The term “alkyl” means an acyclic, saturated, branched, or unbranched, substituent consisting of carbon and hydrogen, for example, methyl, ethyl, propyl, isopropyl, butyl, sec-butyl, isobutyl, and tert- butyl.

The term “aryl” means a cyclic, aromatic substituent consisting of hydrogen and carbon, for example, phenyl, naphthyl, and biphenyl.

The term “halo” means fluoro, chloro, bromo, and iodo.

The term “haloalkoxy” means an alkoxy further consisting of, from one to the maximum possible number of identical or different, halos, for example, fluoromethoxy, trifluoromethoxy, 2,2-difluoropropoxy, chloromethoxy, trichloromethoxy, 1,1,2,2-tetrafluoroethoxy, and pentafluoroethoxy.

The term “haloalkyl” means an alkyl further consisting of, from one to the maximum possible number of, identical or different, halos, for example, fluoromethyl, trifluoromethyl, 2,2-difluoropropyl, chloromethyl, trichloromethyl, and 1,1,2,2-tetrafluoroethyl. DETAILED DESCRIPTION OF THIS DISCLOSURE

Scheme One is shown below.

S1a S1b

In Scheme One:

(a) R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH2, NO2, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy;

(b) each R n is independently a (C 1 -C 4 )alkyl, or both R n substituents together form a (C2- Ce)alkyl link between the two oxygen atoms; and

(c) each X is independently F, Cl, Br, or I.

In one embodiment, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH2, NO2, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy, with the proviso that at least one of R 2 , R 3 , and R4 is not H.

In another embodiment each X is independently Cl or Br.

In another embodiment of S1a: R2 and R4 are CF ; R 1 , R , and R 5 are H; and each R n is C H . This molecule is (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene, hereafter referred to as (“S1a-1”).

The reaction in Scheme One is conducted in the presence of a halocyclopropanating reagent that reacts with S1a to produce S1b. In other words, functionally the halocyclopropanating reagent acts as a source of dihalocarbene. Examples of such halocyclopropanating reagents are carbon tetrachloride (CCU), tetrachloroethylene (CI C-CCI ), chloroform (CHCI ), salts of trichloroacetic acid (metals including but not limited to lithium, sodium, potassium, and quaternary ammonium cations), alkyl esters of trichloroacetate, hexafluoroacetone ((F 3 C) 2 CO), hexachloroacetone ((CI 3 C) 2 CO, also known as 1,1, 1,3, 3, 3- hexachloropropan-2-one), and hexabromoacetone ((Br 3 C) 2 CO). In general, while the amount that may be used depends on a particular reagent, a range from about 0.5 moles to about 100 moles of a reagent may be used per mole of S1a. For example, when chloroform is the reagent, a range from about 5 moles to about 100 moles may be used; however, in some cases a range from about 30 moles to about 60 moles may be used. As another example, when hexachloroacetone is the reagent, a range from about 0.5 moles to about 100 moles may be used; however, in some cases, a range from about 1 mole to about 5 moles may be used. Mixtures of halocyclopropanating agents may also be used.

The reaction in Scheme One is conducted in the presence of lithium salts of tertiary alkoxides.

For example, lithium tert-butoxide (LiOC(CH 3 ) 3 , also known as lithium 2-methylpropan-2-olate) and lithium 2-methyl-2-butoxide (also known as lithium tert-amoxide or lithium tert-amylate) may be used. In general, an amount in the range from about 1 mole to about 20 moles per mole of S1a may be used; from about 1 mole to about 15 moles may also be used. Optionally, mixtures of such lithium salts may be used.

The reaction in Scheme One may be conducted in the presence of a co-solvent. Such co- solvents, for example, may be selected from one or more of the following: heptane, hexane, toluene, diglyme, tetrahydrofuran (“THF”), dimethyl carbonate, dimethoxyethane, ethylene glycol methyl ether, tert-butanol (“t-BuOH”), nitrobenzene, chlorobenzene, methyl tert-butyl ether (“MTBE”), 2-methyldecane, and anisole (also known as methoxybenzene). Optionally, mixtures of such co-solvents, for example mixtures of C 9 -C 12 isoalkanes, may be used.

Optionally, the reaction in Scheme One may be conducted in the presence of a phase-transfer catalyst. Such phase-transfer catalysts, for example, benzyltributylammonium chloride, benzytriethylammonium choride, tetrabutylammonium bromide, tetrabutylammonium hexachlorophosphate, N-benzylcinchonidium chloride, (-)-N-dodecyl-N-methylephedrinium bromide, Aliquat® 336 (trioctylmethylammonium chloride). Optionally, mixtures of phase-transfer catalysts may be used.

The reaction in Scheme One may be conducted at ambient temperatures and ambient pressures. However, higher and lower temperatures and pressures may be used. Currently, temperatures from about 0 °C to about 100 °C may be used. However, depending on the reagent or reagents used, other ranges may be used. For example, when chloroform is the reagent, a range from about 0 °C to about 60 °C may be used; in some situations, a range from about 20 °C to about 50 °C may be used; and in other situations, a range from about 25 °C to about 40 °C may be used. As another example, when hexachloroacetone is the reagent, a range from about 0 °C to about 40 °C may be used; however, in some cases a range from about 0 °C to about 25 °C may be used. A pressure from about 10 kilopascal (kPa) to about 1000 kPa may be used, and in some situations a pressure from about 50 kPa to about 150 kPa may be used. Scheme Two is shown below.

S2b-major product S2b-minor product

In Scheme Two:

(a) R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH 2 , NO 2 , (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy;

(b) each Y is independently a OH, OSi((C 1 -C 4 )alkyl) 3 , OSi((C 1 -C 4 )alkyl) 2 ((C 1 -C 4 )alkyl-aryl), OSi((C 1 -C 4 )alkyl) 2 (aryl), OSi((C 1 -C 4 )alkyl)(aryl)2, OC(O)(C 1 -C 4 )alkyl, OC(O)O(C 1 -C 4 )alkyl, OC(O)NH(C 1 -C 4 )alkyl, O(C 1 -C 4 )alkyl-aryl, O-aryl, tetrahydropyranyl, or 1,3-dioxolanyl; and

(c) each X is independently F, Cl, Br, or I.

In one embodiment, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH2, NO2, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy, with the proviso that at least one of R 2 , R 3 , and R4 is not H.

In another embodiment Y is independently OSi(CH 3 ) 3 , OSi(CH 2 CH 3 ) 3 , OSi(CH(CH 3 ) 2 ) 3 , OSi(CH 3 ) 2 phenyl, OBenzyl, O(C(O)NH-tert-butyl), OSi(CH 3 ) 2 -(tert-butyl).

In another embodiment each X is independently Cl or Br.

In another embodiment of S2a: R 2 and R 4 are CF 3 ; R 1 , R 3 , and R 5 are H; and Y is OSi(CH 3 )2(tert- butyl). This molecule is (5R, 6R)-5,6-bis((E)-3,5-bis(trifluoromethyl)styryl)-2,2,3,3,8,8, 9,9-octamethyl- 4,7-dioxa-3,8-disiladecane, hereafter referred to as (“S2a-1”).

The reaction in Scheme Two is conducted in the presence of a halocyclopropanating reagent that converts S2a to S2b-major product. In other words, functionally the halocyclopropanating reagent acts as a source of dihalocarbene. Examples of such halocyclopropanating reagents are carbon tetrachloride (CCl 4 ), tetrachloroethylene (CI 2 C-CCI 2 ), chloroform (CHCI 3 ), salts of trichloroacetic acid (metals including but not limited to lithium, sodium, potassium, and quaternary ammonium cations), alkyl esters of trichloroacetate, hexafluoroacetone ((F 3 C) 2 CO), hexachloroacetone ((Cl 3 C) 2 CO, also known as 1,1,1 ,3,3,3- hexachloropropan-2-one), and hexabromoacetone ((Br 3 C) 2 CO). In general, while the amount that may be used depends on a particular reagent, a range from about 0.5 moles to about 100 moles of a reagent may be used per mole of S2a. For example, when chloroform is the reagent, a range from about 5 moles to about 100 moles may be used; however, in some cases a range from about 30 moles to about 60 moles may be used. As another example, when hexachloroacetone is the reagent, a range from about 0.5 moles to about 100 moles may be used; however, in some cases, a range from about 1 mole to about 5 moles may be used. Mixtures of halocyclopropanating agents may also be used.

The reaction in Scheme Two is conducted in the presence of lithium salts of tertiary alkoxides.

For example, lithium tert-butoxide (LiOC(CH 3 ) 3 , also known as lithium 2-methylpropan-2-olate) and lithium 2-methyl-2-butoxide (also known as lithium tert-amoxide or lithium tert-amylate) may be used. In general, an amount in the range from about 1 mole to about 20 moles per mole of S2a may be used; from about 1 mole to 15 moles may also be used. Optionally, mixtures of such lithium salts may be used.

The reaction in Scheme Two may be conducted in the presence of a co-solvent. Such co- solvents, for example, may be selected from one or more of the following: heptane, hexane, toluene, diglyme, tetrahydrofuran (“THF”), dimethyl carbonate, dimethoxyethane, ethylene glycol methyl ether, tert-butanol (“t-BuOH”), nitrobenzene, chlorobenzene, methyl tert-butyl ether (“MTBE”), 2-methyldecane, and anisole (also known as methoxybenzene). Optionally, mixtures of such co-solvents, for example mixtures of C9-C12 isoalkanes, may be used.

Optionally, the reaction in Scheme Two may be conducted in the presence of a phase-transfer catalyst. Such phase-transfer catalysts, for example, benzyltributylammonium chloride, benzytriethylammonium choride, tetrabutylammonium bromide, tetrabutylammonium hexachlorophosphate. N-benzylcinchonidium chloride, (-)- N-dodecyl-N-methylephedrinium bromide, Aliquat® 336 (trioctylmethylammonium chloride). Optionally, mixtures of phase-transfer catalysts may be used. The reaction in Scheme Two may be conducted at ambient temperatures and ambient pressures. However, higher and lower temperatures and pressures may be used. Currently, temperatures from about 0 °C to about 100 °C may be used. However, depending on the reagent or reagents used, other ranges may be used. For example, when chloroform is the reagent, a range from about 0 °C to about 60 °C may be used; in some situations, a range from about 20 °C to about 50 °C may be used; and in other situations, a range from about 25 °C to about 40 °C may be used. As another example, when hexachloroacetone is the reagent, a range from about 0 °C to about 40 °C may be used; however, in some cases a range from about 0 °C to about 25 °C may be used. A pressure from about 10 kilopascal (kPa) to about 1000 kPa may be used, and in some situations a pressure from about 50 kPa to about 150 kPa may be used.

EXAMPLES

These examples are for illustration purposes and are not to be construed as limiting this disclosure to only the embodiments disclosed in these examples.

Starting materials, reagents, and solvents that were obtained from commercial sources were used without further purification. Anhydrous solvents were purchased as Sure/Seal™ from Aldrich and were used as received. Bases and other reagents were stored in a nitrogen (N )-filled glovebox, unless otherwise stated. Examples using “ambient temperature” were conducted in climate controlled laboratories with temperatures ranging from about 20 °C to about 24 °C. Molecules are given their known names, named according to naming programs within ChemDraw. If such a program is unable to name a molecule, such molecule is named using conventional lUPAC naming rules. 1 H NMR spectral data are in ppm (δ) and were recorded at 400 and 500 MHz; 13 C NMR spectral data are in ppm (δ) and were recorded at 75, 100, or 150 MHz; and 19 F NMR spectral data are in ppm (δ) and were recorded at 471 MHz, unless otherwise stated.

Example 1a: Synthesis of trans-rac-1-(2,2-dichloro-3-(diethoxymethyl)cyclopropyl)-3,5 - bis(trifluoromethyl) benzene

In a 250 milliliter (mL) three-neck round bottom flask equipped with magnetic stir bar and temperature probe, (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (5 grams (g), 14.61 millimoles (mmol)) was dissolved in chloroform (47.1 mL, 584 mmol). Lithium 2-methylpropan-2-olate (11.69 g, 146 mmol) was added to the solution in one portion. The mixture was heated to 40 °C and stirred vigorously for 24 hours. After cooling to ambient temperature, the reaction mixture was washed with water (50 mL) twice and then with brine. The organic layer was separated, dried over anhydrous sodium sulfate, filtered, and concentrated under vacuum by rotary evaporator to obtain the resulting oil containing the desired product (72% conversion to product). Starting material and product were inseparable by silica gel column chromatography (hexanes-ethyl acetate eluent): 1 H NMR (400 MHz, CDCI 3 ) δ 7.83 (s, 1H), 7.71 (s, 2H), 4.64 (d, J = 6.1 Hz, 1 H), 3.82 - 3.55 (m, 4H), 2.94 (d, J = 8.4 Hz, 1 H), 2.35 (dd, J = 8.5, 6.1 Hz, 1 H), 1.32 (t, J = 7.0 Hz, 3H), 1.21 (t, J = 7.1 Hz, 3H); 19 F NMR (471 MHz, CDCI 3 ) δ -62.87.

Examplel b: Synthesis of trans-rac-(2,2-dichloro-3-(diethoxymethyl)cyclopropyl)benzen e

In a vial, (E)-(3,3-diethoxyprop-1-en-1-yl)benzene (200 milligrams (mg), 0.97 mmol) was dissolved in chloroform (3.128 mL, 38.8 mmol). The solution was added to another vial containing lithium tert-butoxide (776 mg, 9.70 mmol, 10 equivalents relative to starting material) weighed out in a glovebox. The reaction was heated to 40 °C and stirred vigorously for 24 hours. After cooling to ambient temperature, the reaction mixture was washed with water (2 mL) twice. The organic layer was separated, dried over anhydrous sodium sulfate, filtered, and concentrated under vacuum by rotary evaporator. The resulting oil was analyzed by 1 H NMR spectroscopy to obtain 1 H-NMR yield using 1,4-dinitrobenzene as an internal standard (82% yield): 1 H NMR (500 MHz, CDCI 3 ) δ 7.40 - 7.26 (m, 5H), 4.61 (d, J = 6.5 Hz, 1H), 3.90 - 3.53 (m, 4H), 2.84 (d, J = 8.6 Hz, 1H), 2.31 (dd, J = 8.6, 6.5 Hz, 1H), 1.31 (t, J = 7.1 Hz, 3H), 1.19 (t, J = 7.0 Hz, 3H).

Examplel c: Synthesis of trans-rac-1, 3-dichloro-5-(2, 2-dichloro-3- diethoxymethyl)cyclopropyl) benzene

In a vial, (E)-1,3-dichloro-5-(3,3-diethoxyprop-1-en-1-yl)benzene (200 mg, 0.727 mmol, 97 weight percent (wt %)) was dissolved in chloroform (2.345 mL, 29.1 mmol). The solution was added to another vial containing lithium tert-butoxide (582 mg, 7.27 mmol, 10 equivalents relative to starting material) weighed out in a glovebox. The reaction mixture was heated to 40 °C and stirred vigorously for 24 hours. After cooling to ambient temperature, the reaction mixture was washed with water (2 mL) twice. The organic layer was separated, dried over anhydrous sodium sulfate, filtered, and concentrated under vacuum by rotary evaporator. The resulting oil was analyzed by 1 H NMR spectroscopy to obtain 1 H-NMR yield using 1,4-dinitrobenzene as an internal standard (71% yield): 1 H NMR (500 MHz, CDCL) δ 7.31 (t, J = 1.9 Hz, 1H), 7.16 - 7.14 (m, 2H), 4.59 (d, J = 6.1 Hz, 1 H), 3.80 - 3.47 (m, 4H), 2.77 (d, J = 8.5 Hz, 1H), 2.25 (dd, J = 8.5, 6.2 Hz, 1 H), 1.30 (t J, = 7.1 Hz, 3H), 1.20 (t, J = 7.0 Hz, 3H).

Example 2a: Synthesis of trans-rac-1-(2,2-dichloro-3-(diethoxymethyl)cyclopropyl)-3,5 - bis(trifluoromethyl) benzene

In a single-neck 50-mL round bottom flask equipped with a nitrogen inlet and magnetic stir bar was added (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (5.00 g, 14.61 mmol, 1 equivalent). Hexachloroacetone (19.34 g, 13.43 mL, 73.0 mmol, 5 equivalents) was added to the flask. Lithium tert- butoxide (3.51 g, 43.8 mmol, 3 equivalents) was added in one portion at 23 °C. The reaction mixture was stirred at 23 °C under a nitrogen atmosphere for 24 hours. Heptane (20 mL) was added. The mixture was washed with water (10 mL) three times. The heptane layer was concentrated. Purification by flash column chromatography on silica gel (eluent: 0 - 50% ethyl acetate in hexanes) afforded the title compound as a yellow solid (5.28 g, 85% yield): 1 H NMR (500 MHz, CDCI 3 ) 7.83 ( δs, 1H), 7.71 (d, J = 1.6 Hz, 2H), 4.64 (d, J = 6.1 Hz, 1 H), 3.81 - 3.67 (m, 3H), 3.66 - 3.57 (m, 1 H), 2.93 (d, J = 8.5 Hz, 1 H), 2.35 (dd, J = 8.5, 6.0 Hz, 1H), 1.32 J (t, = 7.1 Hz, 3H), 1.21 (t J, = 7.1 Hz, 3H); 19 F NMR (471 MHz, CDCIs) -62.89. δ

Example 2b: Synthesis of rac-(2,2-dichloro-3-(diethoxymethyl)cyclopropyl)benzene

In a vial, (E)-(3,3-diethoxyprop-1-en-1-yl)benzene (0.200 g, 0.970 mmol) was dissolved in hexachloroacetone (0.738 mL, 4.85 mmol, 5 equivalents relative to starting material). The solution was added to another vial containing lithium tert-butoxide (0.233 g, 2.91 mmol, 3 equivalents relative to starting material) weighed out in a glove box. The reaction mixture was stirred vigorously for 24 hours at 23 °C. 1,3,5-Trimethoxybenzene was added to the reaction mixture and used as internal standard to calculate yield by 1 H NMR spectroscopy (91% yield).

Example 2c: Synthesis of trans-rac-1-(2,2-dichloro-3-(diethoxymethyl)cyclopropyl)-3,5 - bis(trifluoromethyl) benzene

In a vial, (E)-1,3-dichloro-5-(3,3-diethoxyprop-1-en-1-yl)benzene (200 mg, 0.727 mmol, 97 wt %) was dissolved in hexachloroacetone (0.553 mL, 3.63 mmol). The solution was added to another vial containing lithium tert-butoxide (175 mg, 2.18 mmol, 3 equivalents relative to starting material) weighed out in a glovebox. The reaction mixture was stirred vigorously for 24 hours at 23 °C. 1,3,5-Trimethoxybenzene was added to the reaction mixture and used as internal standard to calculate yield by 1 H NMR spectroscopy (98% yield): 1 H NMR (500 MHz, CDCI 3 ) 7.31 δ (t, J =1.9 Hz, 1H), 7.16 - 7.14 (m, 2H), 4.59 (d, J = 6.2 Hz, 1H), 3.81 - 3.56 (m, 4H), 2.77 (d, J = 8.5 Hz, 1H), 2.25 (dd, J = 8.5, 6.2 Hz, 1H), 1.30 (t, J = 7.0 Hz, 3H), 1.20 (t, J = 7.1 Hz, 3H).

Example 2d: Synthesis of trans-rac-1-(2,2-dichloro-3-(diisopropoxymethyl)cyclopropyl) -3,5- bis(trifluoromethyl) benzene

In a vial, (E)-1-(3,3-diisopropoxyprop-1-en-1-yl)-3,5-bis(trifluorometh yl)benzene (200 mg, 0.540 mmol, 90 wt %) was dissolved in hexachloroacetone (0.411 mL, 2.70 mmol). The solution was added to another vial containing lithium tert-butoxide (130 mg, 1.62 mmol, 3 equivalents relative to starting material) weighed out in a glovebox. The reaction was stirred vigorously for 24 hours at 23 °C. 1,3,5-Trimethoxybenzene was added to the reaction mixture and used as internal standard to calculate yield by 1 H NMR spectroscopy (71% yield): 1 H NMR (500 MHz, CDCI 3 ) 7.8 δ3 (s, 1H), 7.73 (s, 2H), 4.68 (d, J = 6.5 Hz, 1H), 4.12 - 4.07 (m, 1 H), 4.00 - 3.94 (m, 1 H), 2.85 (d, J = 8.5 Hz, 1 H), 2.34 (dd, J = 8.5, 6.4 Hz, 1 H), 1.31 (d, J = 6.2 Hz, 3H), 1.28 (d, J = 4.9 Hz, 3H), 1.19 (d, J = 6.4 Hz, 3H), 1.14 (d, = 6 J.1 Hz, 3H); 19 F NMR (471 MHz, CDCI 3 ) - δ 62.89. Example 3a: Comparison of bases used in reaction to form trans-rac- 1-(2,2-dichloro-3- (diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromethyl)benzene from (E)-1-(3,3-diethoxyprop-1-en-1- yl)-3,5-bis(trifluoromethyl)benzene

The following general procedure was used. Into a scintillation vial inside the glovebox, the base (5.84 mmol, 10 equivalents) was weighed. In a separate vial, (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5- bis(trifluoromethyl)benzene (0.20 g, 0.584 mmol, 1 equivalent) and chloroform (1.885 mL, 23.37 mmol, 40 equivalents) were mixed and then added to the base via syringe at 23 °C. The mixture was stirred for 24 hours at 23 °C. 1,4-Dinitrobenzene was added to the reaction mixture and used as internal standard to calculate yield by 1 H NMR spectroscopy. The results are reported in the table below.

Example 3b: Comparison of bases used in reaction to form trans-rac- 1-(2,2-dichloro-3- (diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromethyl)benzene from (E)-1-(3,3-diethoxyprop-1-en-1- yl)-3,5-bis(trifluoromethyl)benzene Into a scintillation vial inside the glovebox, the base (1.753, 3 equivalents) was weighed. In a separate vial, (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (0.20 g, 0.584 mmol, 1 equivalent) and hexachloroacetone (0.445 mL, 2.92 mmol, 5 equivalents) were mixed and then added to the solid base via syringe at 23 °C. The mixture was stirred for 24 hours at 23 °C. 1,3,5-Trimethoxybenzene was added to the reaction mixture and used as internal standard to calculate yield by 1 H NMR spectroscopy. The results are reported in the table below.

Example 4a: Comparison of amount of base used in reaction to form trans-rac- 1-(2,2-dichloro-3- (diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromethyl)benzene from (E)-1-(3,3-diethoxyprop-1-en-1- yl)-3,5-bis(trifluoromethyl)benzene

In a vial, (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (200 mg, 0.584 mmol) was dissolved in chloroform (1.9 mL, 23.37 mmol). Lithium tert-butoxide (5 to 15 equivalents) was added to the solution in one portion. The mixture was heated to 40 °C and stirred vigorously for 24 hours. After cooling to ambient temperature, the reaction mixture was washed with water (2 mL) twice. The organic layer was separated, dried over anhydrous sodium sulfate, filtered, and concentrated under vacuum by rotary evaporator. The resulting oil was analyzed by 1 H NMR spectroscopy to obtain 1 H NMR yield using 1 ,4- dinitrobenzene as an internal standard. The results are reported in the table below.

Example 4b: Comparison of amount of base used in reaction to form trans-rac- 1-(2,2-dichloro-3- (diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromethyl)benzene from (E)-1-(3,3-diethoxyprop-1-en-1- yl)-3,5-bis(trifluoromethyl)benzene

Into a scintillation vial inside the glovebox, lithium tert-butoxide was weighed. In a separate vial, (E)-1-(3,3- diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)benzene (0.20 g, 0.584 mmol, 1 equivalent) and hexachloroacetone (0.445 mL, 2.92 mmol, 5 equivalents) were mixed and then added to the solid base via syringe at 23 °C. The mixture was stirred for 24 hours at 23 °C. 1,3,5-Trimethoxybenzene was added to the reaction mixture and used as internal standard to calculate yield by 1 H NMR spectroscopy. The results are reported in the table below.

Example 5a: Comparison of bases and temperatures used in reaction to form trans-rac- 1 -(2,2- dichloro-3-(diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromet hyl)benzene from (E)-1-(3,3- diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl) benzene

In a vial (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (0.25 g, 0.730 mmol) was dissolved in chloroform (2.356 mL, 29.2 mmol). The mixture was set to the indicated temperature, and a base (6-10 equivalents) was added. The mixture was stirred for 18 hours. Conversion was analyzed by 1 H NMR spectroscopy. Example 5b: Comparison of bases used in reaction to form trans-rac- 1-(2,2-dichloro-3- (diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromethyl)benzene from (E)-1-(3,3-diethoxyprop-1-en-1- yl)-3,5-bis(trifluoromethyl)benzene

In a vial (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (0.20 g, 0.584 mmol) was dissolved in hexachloroacetone (0.356 mL, 2.337 mmol, 4 equivalents) at 23 °C. Base (1.5-3 equivalents) was added. The mixture was stirred for 24 hours. Conversion was analyzed by 1 H NMR spectroscopy.

Example 6a: Comparison of co-solvents and bases used in reaction to form trans-rac- 1 -(2,2- dichloro-3-(diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromet hyl)benzene from (E)-1-(3,3- diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl) benzene

In a vial (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (0.25 g, 0.730 mmol) was dissolved in chloroform (2.356 mL, 29.2 mmol). The mixture was set to the indicated temperature, and a base (6-10 equivalents) was added either as a solid or as a suspension with indicated co-solvents. The mixture was stirred for 18 hours. Conversion was analyzed by 1 H NMR spectroscopy.

Example 6b: Comparison of co-solvents used in reaction to form trans-rac- 1-(2,2-dichloro-3- (diethoxymethyl)cyclopropyl)-3,5-bis(trifluoromethyl)benzene from (E)-1-(3,3-diethoxyprop-1-en-1- yl)-3,5-bis(trifluoromethyl)benzene

In a vial (E)-1-(3,3-diethoxyprop-1-en-1-yl)-3,5-bis(trifluoromethyl)b enzene (0.20 g, 0.584 mmol) was dissolved in hexachloroacetone (0.445 mL, 2.92 mmol, 5 equivalents) and the indicated co-solvent. The mixture was set to the indicated temperature, and lithium tert-butoxide (0.234 g, 2.92 mmol) was added. The mixture was stirred for 18 hours. Conversion was analyzed by 1 H NMR spectroscopy.

Example 7: Synthesis of (5R, 6R)-5,6-bis((1R, 3R)-3-(3,5-bis(trifluoromethyl)phenyl)-2,2- dichlorocyclopropyl)-2,2,3,3,8,8,9,9-octamethyl-4,7-dioxa-3, 8-disiladecane

S7b-1 S7b-2

Desired product and Minor product major product

In a vial (5R, 6R)-5,6-bis((E)-3,5-bis(trifluoromethyl)styryl)-2,2,3,3,8,8, 9,9-octamethyl-4,7-dioxa-3,8- disiladecane (0.25 g, 0.326 mmol) was mixed with hexachloroacetone (0.495 mL, 3.26 mmol). Lithium 2- methylpropan-2-olate (0.130 g, 1.630 mmol) was added in one portion. The mixture was stirred overnight at ambient temperature. After 18 hours, analysis by 1 H NMR spectroscopy showed >99% conversion of the starting material to the desired product with a diastereoselectivity ratio (dr) of -5.5:1 favoring desired product. The reaction was quenched with water and the organic layer was separated, dried, and concentrated to an oil. No isolated yield was obtained.

Example 8: Synthesis of (5R, 6R)-5,6-bis((1R, 3R)-3-(3,5-bis(trifluoromethyl)phenyl)-2,2- dichlorocyclopropyl)-2,2,3,3,8,8,9,9-octamethyl-4,7-dioxa-3, 8-disiladecane

S7b-1 S7b-2

Major product Minor product

In a vial (5R, 6R)-5,6-bis((E)-3,5-bis(trifluoromethyl)styryl)-2,2,3,3,8,8, 9,9-octamethyl-4,7-dioxa-3,8- disiladecane (0.25 g, 0.326 mmol) and lithium 2-methylpropan-2-olate (0.391 g, 4.89 mmol) were added. To the solids, chloroform (1.841 mL, 22.82 mmol) was added. The mixture was heated to 40 °C and stirred for 18 hours affording desired product with a significant amount of mono-cyclopropanated material. An additional 5 equivalents of lithium 2-methylpropan-2-olate were added (0.13 g) and the mixture was stirred for an additional day. After 40 hours, 1 H NMR analysis showed -15% of alkene mono- cyclopropanated species and -85% conversion to desired product (dr was not determined). The reaction was quenched with water and the organic layer was separated, dried, and concentrated to an oil. No isolated yield was obtained.

Example M1 : Synthesis of (5R, 6R)-2,2,3,3,8,8,9,9-octamethyl-5,6-divinyl-4,7-dioxa-3,8-dis iladecane

In a four-neck reactor equipped with a mechanical stirrer, condenser, nitrogen inlet and temperature probe, (3/?,4/?)-hexa-1,5-diene-3,4-diol (60 g, 526 mmol) was stirred in anhydrous N,N-dimethylformamide (DMF, 394 mL) (It should be noted that DMF could have been replaced by acetonitrile, or a mixture of acetonitrile and DMF could have been used). The mixture was cooled to 0-5 °C. Imidazole (140 g, 2050 mmol) was added. A solution of tert-butylchlorodimethylsilane (158 g, 1051 mmol, 2 equivalents) in heptane (131 mL) was added via addition funnel (temperature < 5 °C). The mixture was warmed to ambient temperature and stirred for 20 hours. Methanol (15.95 mL, 394 mmol, 0.75 equivalents) was added with stirring at ambient temperature. After 1 hour, the mixture was charged with heptane (1.5 L) and was stirred vigorously for 10-15 minutes. Stirring was stopped and the layers separated. The heptane portion (top layer) was collected and washed/partitioned with acetonitrile (2 x 100 mL). The heptane portion was concentrated to provide the title compound as a colorless oil, which was used without further manipulation (178 g, 95% yield, 96% purity): 1 H NMR (400 MHz, CDCI 3 ) 6.28 - δ 5.60 (m, 2H), 5.26 - 5.04 (m, 4H), 4.17 - 4.06 (m, 2H), 0.91 (s, 18H), 0.07 (s, 6H). 0.05 (s, 6H).

Example M2: Synthesis of (5R, 6R)-5,6-bis((E)-3,5-bis(trifluoromethyl)styryl)-2,2,3,3,8,8, 9,9- octamethyl-4,7-dioxa-3,8-disiladecane

The reaction was conducted under nitrogen in a four-neck 1-L jacketed reactor equipped with a mechanical stirrer, temperature probe, nitrogen inlet and baffle. 1-Bromo-3,5-bis(trifluoromethyl)benzene (115 g, 394 mmol) and (5R, 6R)-2,2,3,3,8,8,9,9-octamethyl-5,6-divinyl-4,7-dioxa-3,8-dis iladecane (50 g,

146 mmol) were stirred in DMF (365 mL). Potassium carbonate (38.3 g, 277 mmol), sodium acetate (15.56 g, 190 mmol) and diacetoxypalladium (1.31 g, 5.84 mmol, 4 mol %) were added. The mixture was heated to an internal temperature of 66 °C. After 24 hours, heating was ceased. While the reaction was warm, acetonitrile (500 mL) and heptane (1 L) were added with stirring. Upon cooling to ambient temperature stirring was stopped and the layers separated. The DMF portion (bottom layer) along with solid salts were drained from the reactor. The heptane portion (top layer) was collected. The bottom layer was back extracted with heptane (500 mL). The heptane layers were combined, washed with acetonitrile (2 x 200 mL), and concentrated to provide the title compound as an off-white solid (99.3 g, 84% yield): 1 H NMR (400 MHz, CDCI 3 ) δ 7.70 (s, 6H), 6.62 (dd, J = 16.0, 1.1 Hz, 2H), 6.43 (ddd, J = 16.0, 3.3, 1.2 Hz, 2H), 4.66 - 4.21 (m, 2H), 0.98 (s, 18H), 0.15 (s, 6H), 0.12 (s, 6H); 19 F NMR (376 MHz, CDCI 3 ) -63.09. δ

Consequently, considering the above the following additional, non-exhaustive, disclosure details

(d) are provided.

Additional details related to Scheme One.

1d. A process comprising halocyclopropanating S1a to produce S1b in the presence of a halocyclopropanating reagent and a lithium salt of tertiary alkoxide

S1a S1b wherein

(a) R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH , NO , (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy;

(b) each R n is independently a (C 1 -C 4 )alkyl, or both R n substituents together form a (C - Ce)alkyl link between the two oxygen atoms; and

(c) each X is independently F, Cl, Br, or I.

2d. A process according to the previous detail wherein R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH 2 , NO , (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy, with the proviso that at least one of R 2 , R 3 , and R 4 is not H.

3d. A process according to any of the previous details wherein each R n is independently a (C 1 -

C 4 )alkyl. 4d. A process according to any of the previous details wherein each X is independently Cl or Br.

5d. A process according to any of the previous details wherein each X is Cl.

6d. A process according to any of the previous details wherein S1a has R and R are CF ; R 1 , R , and

R are H; and each R n is C H .

7d. A process according to any of the previous details wherein said halocyclopropanating reagent is carbon tetrachloride (CCI 4 ), tetrachloroethylene (CI 2 C-CCI 2 ), chloroform (CHCI ), salts of trichloroacetic acid (metals including, but not limited to, lithium, sodium, potassium, and quaternary ammonium cations), alkyl esters of trichloroacetate, hexafluoroacetone ((F 3 C) 2 CO), hexachloroacetone ((Cl 3 C) 2 CO, also known as 1,1,1,3,3,3-hexachloropropan-2-one), hexabromoacetone ((Br 3 C) 2 CO), and mixtures of said halocyclopropanating reagents.

8d. A process according to any of the previous details wherein said halocyclopropanating reagent is hexachloroacetone.

9d. A process according to any of the previous details wherein the amount of halocyclopropanating reagent present during the halocyclopropanating is from about 0.5 moles to about 100 moles of reagent per mole of S1a.

10d. A process according to any of the previous details wherein said halocyclopropanating agent is chloroform and the amount of chloroform present during the halocyclopropanating is from about 5 moles to about 100 moles of reagent per mole of S1a.

11d. A process according to any of the previous details wherein said halocyclopropanating agent is chloroform and the amount of chloroform present during the halocyclopropanating is from about 30 moles to about 60 moles of reagent per mole of S1a.

12d. A process according to any of the previous details wherein said halocyclopropanating agent is hexachloroacetone and the amount of hexachloroacetone present during the halocyclopropanating is from about 0.5 moles to about 100 moles of reagent per mole of S1a.

13d. A process according to any of the previous details wherein said halocyclopropanating agent is hexachloroacetone and the amount of hexachloroacetone present during the halocyclopropanating is from about 1 moles to about 5 moles of reagent per mole of S1a. 14d. A process according to any of the previous details wherein said halocyclopropanating agent is a mixture of hexachloroacetone and chloroform, and wherein chloroform is in an molar amount less than the molar amount of hexachloroacetone.

15d. A process according to any of the previous details wherein said lithium salt of tertiary alkoxide is lithium tert-butoxide (LiOC(CH 3 ) 3 , also known as lithium 2-methylpropan-2-olate) or lithium 2-methyl-2- butoxide (also known as lithium tert-amoxide or lithium tert-amylate), or a mixture thereof.

16d. A process according to any of the previous details wherein said lithium salt of tertiary alkoxide is lithium tert-butoxide (LiOC(CH 3 ).

17d. A process according to any of the previous details wherein the amount of said lithium salt of tertiary alkoxide present during the halocyclopropanating is from about 1 mole to about 20 moles of lithium salt of tertiary alkoxide per mole of S1a.

18d. A process according to any of the previous details wherein the amount of said lithium salt of tertiary alkoxide present during the halocyclopropanating is from about 1 mole to about 15 moles of lithium salt of tertiary alkoxide per mole of S1a.

19d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a co-solvent.

20d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a co-solvent selected from one or more of the following: heptane, hexane, toluene, diglyme, tetrahydrofuran (“THF”), dimethyl carbonate, dimethoxyethane, ethylene glycol methyl ether, tert-butanol (“t-BuOH”), nitrobenzene, chlorobenzene, methyl tert-butyl ether (“MTBE”), 2 methyldecane, anisole (also known as methoxybenzene), and mixtures of C 9 -C 12 isoaikanes.

21d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a phase-transfer catalyst.

22d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a phase-transfer catalyst selected from benzyltributylammonium chloride, benzytriethylammonium choride, tetrabutylammonium bromide, tetrabutylammonium hexachlorophosphate, N-benzylcinchonidium chloride, (-)-N-dodecyl-N-methylephedrinium bromide, trioctylmethylammonium chloride, and mixtures thereof.

23d. A process according to any of the previous details wherein said halocyclopropanating is conducted at ambient temperatures and ambient pressures.

24d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 0 °C to about 100 °C.

25d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 0 °C to about 60 °C and said halocyclopropanating reagent is chloroform.

26d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 20 °C to about 50 °C and said halocyclopropanating reagent is chloroform.

27d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 25 °C to about 40 °C and said halocyclopropanating reagent is chloroform.

28d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 0 °C to about 40 °C and said halocyclopropanating reagent is hexachloroacetone.

29d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 20 °C to about 25 °C and said halocyclopropanating reagent is hexachloroacetone.

30d. A process according to any of the previous details wherein said halocyclopropanating is conducted at a pressure from about 10 kilopascal (kPa) to about 1000 kPa or at a pressure from about 50 kPa to about 150 kPa.

Additional details related to Scheme Two. 1d. A process comprising halocyclopropanating S2a to produce S2b-major product in the presence of a halocyclopropanating reagent and a lithium salt of tertiary alkoxide

S2b-major product S2b-minor product wherein

(a) R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH 2 , NO 2 , (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy;

(b) each Y is independently a OH, OSi((C 1 -C 4 )alkyl) 3 , OSi((C 1 -C 4 )alkyl) 2 ((C 1 -C 4 )alkyl-aryl), OSi((C 1 -C 4 )alkyl) 2 (aryl), OSi((C 1 -C 4 )alkyl)(aryl) 2 , OC(O)(C 1 -C 4 )alkyl, OC(O)O(C 1 -C 4 )alkyl, OC(O)NH(C 1 - C 4 )alkyl, O(C 1 -C 4 )alkyi-aryl, O-aryl, tetrahydropyranyl, or 1,3-dioxolanyl; and

(c) each X is independently F, Cl, Br, or I.

2d. A process according to the previous detail wherein R 1 , R 2 , R 3 , R 4 , and R 5 are each independently H, F, Cl, Br, I, CN, NH 2 , NO2, (C 1 -C 4 )alkyl, (C 1 -C 4 )alkoxy, (C 1 -C 4 )haloalkyl, or (C 1 -C 4 )haloalkoxy, with the proviso that at least one of R 2 , R 3 , and R 4 is not H.

3d. A process according to any of the previous details wherein each Y is independently OSi(CH 3 ) 3 , OSi(CH 2 CH 3 ) 3 , OSi(CH(CH 3 ) 2 ) 3 , OSi(CH 3 ) 2 phenyl, OBenzyl, O(C(O)NH-tert-butyi), OSi(CH 3 ) 2 -(tert-butyl).

4d. A process according to any of the previous details wherein each Y is OSi(CH 3 ) 2 -(tert-butyl). 5d. A process according to any of the previous details wherein each X is independently Cl or Br.

6d. A process according to any of the previous details wherein each X is Cl.

7d. A process according to any of the previous details wherein S2a: R 2 and R 4 are CF ; R 1 , R 3 , and R 5 are H; and Y is OSi(CH 3 ) 2 (tert-butyl).

8d. A process according to any of the previous details wherein said halocyclopropanating reagent is carbon tetrachloride (CCl 4 ), tetrachloroethylene (CI 2 C-CCI 2 ), chloroform (CHCI 3 ,) salts of trichloroacetic acid (metals including, but not limited to, lithium, sodium, potassium, and quaternary ammonium cations), alkyl esters of trichloroacetate, hexafluoroacetone ((F 3 C) 2 CO), hexachloroacetone ((CI 3 C) 2 CO, also known as 1,1,1,3,3,3-hexachloropropan-2-one), hexabromoacetone ((Br 3 C) 2 CO), and mixtures of said halocyclopropanating reagents.

9d. A process according to any of the previous details wherein said halocyclopropanating reagent is hexachloroacetone.

10d. A process according to any of the previous details wherein the amount of halocyclopropanating reagent present during the halocyclopropanating is from about 0.5 moles to about 100 moles of reagent per mole of S1a.

11d. A process according to any of the previous details wherein said halocyclopropanating agent is chloroform and the amount of chloroform present during the halocyclopropanating is from about 5 moles to about 100 moles of reagent per mole of S1a.

12d. A process according to any of the previous details wherein said halocyclopropanating agent is chloroform and the amount of chloroform present during the halocyclopropanating is from about 30 moles to about 60 moles of reagent per mole of S1a.

13d. A process according to any of the previous details wherein said halocyclopropanating agent is hexachloroacetone and the amount of hexachloroacetone present during the halocyclopropanating is from about 0.5 moles to about 100 moles of reagent per mole of S1a.

14d. A process according to any of the previous details wherein said halocyclopropanating agent is hexachloroacetone and the amount of hexachloroacetone present during the halocyclopropanating is from about 1 moles to about 5 moles of reagent per mole of S1a. 15d. A process according to any of the previous details wherein said halocyclopropanating agent is a mixture of hexachloroacetone and chloroform, and wherein chloroform is in an molar amount less than the molar amount of hexachloroacetone.

16d. A process according to any of the previous details wherein said lithium salt of tertiary alkoxide is lithium tert-butoxide (LiOC(CH 3 ) 3 , also known as lithium 2-methylpropan-2-olate) or lithium 2-methyl-2- butoxide (also known as lithium tert-amoxide or lithium tert-amylate), or a mixture thereof.

17d. A process according to any of the previous details wherein said lithium salt of tertiary alkoxide is lithium tert-butoxide (LiOC(CH 3 ).

18d. A process according to any of the previous details wherein the amount of said lithium salt of tertiary alkoxide present during the halocyclopropanating is from about 1 mole to about 20 moles of lithium salt of tertiary alkoxide per mole of S1a.

19d. A process according to any of the previous details wherein the amount of said lithium salt of tertiary alkoxide present during the halocyclopropanating is from about 1 mole to about 15 moles of lithium salt of tertiary alkoxide per mole of S1a.

20d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a co-solvent.

21d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a co-solvent selected from one or more of the following: heptane, hexane, toluene, diglyme, tetrahydrofuran (“THF”), dimethyl carbonate, dimethoxyethane, ethylene glycol methyl ether, tert-butanol (“t-BuOH”), nitrobenzene, chlorobenzene, methyl tert-butyl ether (“MTBE”), 2 methyldecane, anisole (also known as meihoxybenzene), and mixtures of C 9 -C 12 isoaikanes.

22d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a phase-transfer catalyst.

23d. A process according to any of the previous details wherein said halocyclopropanating is conducted in the presence of a phase-transfer catalyst selected from benzyltributylammonium chloride, benzytriethylammonium choride, tetrabutylammonium bromide, tetrabutylammonium hexachlorophosphate, N-benzylcinchonidium chloride, (-)-N-dodecyl-N-methylephedrinium bromide, trioctylmethylammonium chloride, and mixtures thereof.

24d. A process according to any of the previous details wherein said halocyclopropanating is conducted at ambient temperatures and ambient pressures.

25d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 0 °C to about 100 °C.

26d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 0 °C to about 60 °C and said halocyclopropanating reagent is chloroform.

27d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 20 °C to about 50 °C and said halocyclopropanating reagent is chloroform.

28d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 25 °C to about 40 °C and said halocyclopropanating reagent is chloroform.

29d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 0 °C to about 40 °C and said halocyclopropanating reagent is hexachloroacetone.

30d. A process according to any of the previous details wherein said halocyclopropanating is conducted at temperatures from about 20 °C to about 25 °C and said halocyclopropanating reagent is hexachloroacetone.

31d. A process according to any of the previous details wherein said halocyclopropanating is conducted at a pressure from about 10 kilopascal (kPa) to about 1000 kPa or at a pressure from about 50 kPa to about 150 kPa.

Details related to molecules

1d. A composition comprising one or more of the following molecules:

d. A molecule having the following structure

3d. A molecule having the following structure

End of details.




 
Previous Patent: MULTI-TIER FRICTION LINER

Next Patent: RAS INHIBITORS